The training aimed to equip selected staff to take on the role of DAT administrator after the ASCENT project phases out in December 2022.
Dr. Andre Daniel E. Villanueva shared with the teams from the PricewaterhouseCoopers (PwC) network around the world the value of digital adherence technology (DAT).
ASCENT Philippines urged the health facilities in Bulacan province implementing digital adherence technology to continue offering DAT, even beyond the research phase of the project.
ASCENT Philippines and other development partners joined the Department of Health Central Luzon Center for Health Development to celebrate the National Tuberculosis Day on 19 August 2022.
ASCENT Philippines and the Department of Health (DOH) are enhancing the capability of the ASCENT adherence platform by making the platform and the DOH Integrated Tuberculosis Information System interoperable.
With the ASCENT project ending on 31 December 2022, the ASCENT Philippines team held separate meetings with key partners in the Philippines to prime them for the scale-up of DAT implementation.
In March 2022, Richard Clores, the nurse who attends to drug-resistant tuberculosis (DRTB) patients at the Bulacan Medical Center PMDT satellite treatment center in Bulacan province, Philippines, enrolled five patients in the use of digital adherence technology (DAT).
Dr. Jakob Simmank, the head of the health section of Die Zeit, an online newspaper in Hamburg, Germany, is preparing an article on the fight against tuberculosis (TB), including the use of digital adherence technology (DAT) for TB treatment.
Bulacan, Philippines celebrated World TB Day 2022 with Governor Daniel Fernando signing the Memorandum of understanding (MOU) between KNCV Tuberculosis Foundation and the Department of Health of the Philippines.
ASCENT Philippines gathered drug-resistant tuberculosis (DRTB) patients to guide them in their use of digital adherence technology (DAT), in particular video-supported treatment (VOT) using the SureAdhere app and the evriMED smart pillbox.